by Isogenica Webmaster | Apr 2018 | Press Releases, Welcome
Fusion Pharmaceuticals Licenses Isogenica’s CIS Display Technology Fusion Pharmaceuticals Licenses Isogenica’s CIS Display Technology. Technology will be used to progress Fusion’s pipeline of alpha therapeutics for the treatment of cancers. Isogenica Ltd and Fusion...